You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-cell depletion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Miltenyi CliniMACS Prodigy ® system
  • (no location specified)
Mar 23, 2023

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

Immunodeficiencies Trial in Philadelphia (CliniMACs)

Active, not recruiting
  • Immunodeficiencies
  • CliniMACs
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Mar 1, 2022

Hematologic Malignancies Trial in Milwaukee (CliniMACs)

Active, not recruiting
  • Hematologic Malignancies
  • CliniMACs
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Apr 4, 2022

Nephrotic Syndrome Trial in Ranica (Blood sampling)

Recruiting
  • Nephrotic Syndrome
  • Blood sampling
  • Ranica, BG, Italy
    Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Jan 25, 2023

Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)

Recruiting
  • Leukemia
  • +2 more
  • Alpha Beta T cell depletion
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Oct 27, 2021

Sickle Cell Disease, Thalassemia Major Trial in Philadelphia (CliniMACS)

Recruiting
  • Sickle Cell Disease
  • Thalassemia Major
  • CliniMACS
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Dec 22, 2021

Multiple Sclerosis Trial in Baltimore (Belimumab, Short-course Ocrelizumab, Continued Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • Baltimore, Maryland
    Johns Hopkins University
Oct 7, 2021

Acquired Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Inherited Bone Marrow Failure Syndromes Trial in Philadelphia

Recruiting
  • Acquired Aplastic Anemia
  • +2 more
  • CliniMACs
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Mar 1, 2022

Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical

Recruiting
  • Hemoglobinopathy (Disorder)
  • +2 more
  • Haploidentical Hematopoietic Cell Transplantation
  • Saint Petersburg, Florida
    Johns Hopkins All Children's Hospital
Sep 13, 2022

Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
  • Palo Alto, California
    Lucile Packard Children's Hospital
Feb 2, 2022

Immune Cells and Meningeal Lymphatic Drainage in Demyelinating

Recruiting
  • Multiple Sclerosis
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University General Hospital
Oct 19, 2022

Malignant Diseases (ie, Leukemia, MDS, Lymphoma), Non-malignant Diseases (ie, Bone Marrow Failure Syndromes) Trial in Milwaukee

Completed
  • Malignant Diseases (ie, Leukemia, MDS, Lymphoma)
  • Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
  • CliniMACS (CD+3, CD+19 depletion)
  • +2 more
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Oct 21, 2021

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

SIOD With CKD Stage 3 Through 5, Cystinosis With CKD Stage 3 Through 5, FSGS With CKD Stage 3 Through 5 Trial in Palo Alto

Not yet recruiting
  • SIOD With CKD Stage 3 Through 5
  • +3 more
  • Cyclophosphamide 1200 mg/Kg
  • +8 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Aug 17, 2022

DLBCL, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma Trial in Minneapolis (E7777)

Recruiting
  • DLBCL
  • +3 more
  • Minneapolis, Minnesota
    University of Minnesota, Masonic Cancer Center
Jul 1, 2022

Chronic Fatigue Syndrome Trial in Bergen (Rituximab, Saline (NaCl 0,9 %) ())

Completed
  • Chronic Fatigue Syndrome
  • Bergen, Norway
    Department of Oncology and Medical Physics, Haukeland University
May 10, 2021

Primary Immune Deficiency Disorders, Metabolic Disease Trial in Saint Petersburg (Haploidentical Hematopoietic Cell

Recruiting
  • Primary Immune Deficiency Disorders
  • Metabolic Disease
  • Haploidentical Hematopoietic Cell Transplantation
  • Saint Petersburg, Florida
    Johns Hopkins All Children's Hospital
Sep 9, 2021

Hematologic Diseases Trial in Palo Alto (biological, device, drug)

Recruiting
  • Hematologic Diseases
  • Allogeneic Stem Cell Transplant
  • +2 more
  • Palo Alto, California
    Lucile Packard Children's Hospital
Mar 25, 2022

Immune Thrombocytopenia (ITP), Systemic Lupus Erythematosus (SLE) Trial in Créteil, Paris (Bliss-Believe)

Unknown status
  • Immune Thrombocytopenia (ITP)
  • Systemic Lupus Erythematosus (SLE)
  • Bliss-Believe
  • Créteil, France
  • +1 more
May 21, 2021

Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

Not yet recruiting
  • Graft Vs Host Disease
  • +5 more
  • CliniMACS® device
  • (no location specified)
Jul 20, 2023

Pediatric Hematologic Malignancies Trial in Saint Louis (Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs

Not yet recruiting
  • Pediatric Hematologic Malignancies
  • Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs Plus
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 20, 2022

Highly Sensitized Prospective Kidney Transplant Recipients Trial in San Francisco (daratumumab, belatacept, Bone marrow

Recruiting
  • Highly Sensitized Prospective Kidney Transplant Recipients
  • daratumumab
  • +2 more
  • San Francisco, California
    University of California at San Francisco Medical Center
Jan 27, 2022

Graft Vs Host Disease, Graft-versus-host-disease Trial in San Francisco (CliniMacs®)

Recruiting
  • Graft Vs Host Disease
  • Graft-versus-host-disease
  • CliniMacs®
  • San Francisco, California
    University of California, San Francisco
Aug 2, 2022